In the August 14, 2014, Federal Register, FDA reopened the comment period for the draft guidance Best Practices in Developing Proprietary Names for Drugs. The draft guidance was initially published in the May 29, 2014, Federal Register. FDA reopened the comment period in response to requests stating the original 60-day comment period, which closed on July 28, 2014, did not allow sufficient time to develop a meaningful or thoughtful response. Comments due September 15, 2014.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
